Insights from a professor of microbiology and immunology 
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
 


<[link removed]>

John,

Omicron, the COVID-19 variant first identified by scientists in South Africa,
has now appeared in countries around the world -- and in multiple U.S. states.

Reports on Omicron have been limited by a lack of robust data, but
researchers are learning more by the day. We asked Dr. Andrew Pekosz, a
professor of microbiology and immunology at the Johns Hopkins Bloomberg School
of Public Health, to provide insights based on what we know so far.

He shared three reasons why Omicron is concerning, and what this might mean
for vaccines.
<[link removed]>


<[link removed]>

WATCH NOW
<[link removed]>

SHARE ON FACEBOOK
<[link removed]>

SHARE ON TWITTER
<[link removed]>

SHARE ON LINKEDIN
<[link removed]>
Right now -- as always -- it's critical to listen to public health experts,
and take every step available to safeguard yourself and others.

Watch our latest Road to Recovery for more on what we know (and don't know)
about Omicron:


[link removed]

<[link removed]>

Thanks,

Bloomberg Philanthropies

 

<[link removed]>
<[link removed]>
<[link removed]>
<[link removed]>
<[link removed]>  
About our work

Bloomberg Philanthropies invests in 810 cities and 170 countries around the
world to ensure better, longer lives for the greatest number of people. The
organization focuses on five key areas for creating lasting change: Public
Health, Education, Government Innovation, Environment, and the Arts.


<[link removed]>
Public Health

<[link removed]>
Education

<[link removed]>
Government
Innovation

<[link removed]>
Environment

<[link removed]>
The Arts

Bloomberg Philanthropies encompasses all of Michael R. Bloomberg's giving,
including his foundation, corporate, and personal philanthropy as well as
Bloomberg Associates, a pro bono consultancy that works in cities around the
world. In 2020, Bloomberg Philanthropies distributed $1.6 billion.

Learn more at Bloomberg.org
<[link removed]>

Click here to unsubscribe
<[link removed]>
.

Bloomberg Philanthropies

All content ©2021 Bloomberg IP Holdings LLC. All rights reserved.